- Home
- ORKA vs NRDS Comparison
ORKA vs NRDS Comparison
Compare ORKA & NRDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- NRDS
- Stock Information
- Founded
- ORKA 2004
- NRDS 2009
- Country
- ORKA United States
- NRDS United States
- Employees
- ORKA N/A
- NRDS N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NRDS EDP Services
- Sector
- ORKA Health Care
- NRDS Technology
- Exchange
- ORKA Nasdaq
- NRDS Nasdaq
- Market Cap
- ORKA 580.3M
- NRDS 785.4M
- IPO Year
- ORKA N/A
- NRDS 2021
- Fundamental
- Price
- ORKA $16.58
- NRDS $11.28
- Analyst Decision
- ORKA Strong Buy
- NRDS Buy
- Analyst Count
- ORKA 7
- NRDS 5
- Target Price
- ORKA $43.00
- NRDS $13.80
- AVG Volume (30 Days)
- ORKA 224.5K
- NRDS 485.7K
- Earning Date
- ORKA 11-12-2025
- NRDS 10-28-2025
- Dividend Yield
- ORKA N/A
- NRDS N/A
- EPS Growth
- ORKA N/A
- NRDS N/A
- EPS
- ORKA N/A
- NRDS 0.60
- Revenue
- ORKA N/A
- NRDS $771,200,000.00
- Revenue This Year
- ORKA N/A
- NRDS $16.45
- Revenue Next Year
- ORKA N/A
- NRDS $7.85
- P/E Ratio
- ORKA N/A
- NRDS $18.53
- Revenue Growth
- ORKA N/A
- NRDS 28.75
- 52 Week Low
- ORKA $5.49
- NRDS $7.55
- 52 Week High
- ORKA $31.13
- NRDS $16.45
- Technical
- Relative Strength Index (RSI)
- ORKA 59.72
- NRDS 60.38
- Support Level
- ORKA $14.67
- NRDS $10.77
- Resistance Level
- ORKA $18.50
- NRDS $11.39
- Average True Range (ATR)
- ORKA 1.11
- NRDS 0.36
- MACD
- ORKA 0.01
- NRDS 0.09
- Stochastic Oscillator
- ORKA 50.64
- NRDS 92.36
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.